Published in Curr Top Microbiol Immunol on January 01, 2012
Stability of influenza vaccine coated onto microneedles. Biomaterials (2012) 1.04
Applications of nanotechnology in dermatology. J Invest Dermatol (2012) 1.00
Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol (2014) 0.97
Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One (2012) 0.96
Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. Eur J Pharm Biopharm (2012) 0.88
Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol (2014) 0.86
Laser vaccine adjuvants. History, progress, and potential. Hum Vaccin Immunother (2014) 0.82
New routes for allergen immunotherapy. Hum Vaccin Immunother (2012) 0.81
An update on the use of laser technology in skin vaccination. Expert Rev Vaccines (2013) 0.81
DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Mol Ther Methods Clin Dev (2014) 0.79
Classification of Laser Vaccine Adjuvants. J Vaccines Vaccin (2016) 0.78
COX-2 Inhibition Reduces Brucella Bacterial Burden in Draining Lymph Nodes. Front Microbiol (2016) 0.76
Semiconductor diode laser device adjuvanting intradermal vaccine. Vaccine (2017) 0.76
Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice. PLoS One (2015) 0.75
A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin. J Vis Exp (2016) 0.75
Thermal Assisted In Vivo Gene Electrotransfer. Curr Gene Ther (2016) 0.75
Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine (2016) 0.75
A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo. Hum Vaccin Immunother (2014) 0.75
Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine. J Immunol (2017) 0.75
Microfabrication for Drug Delivery. Materials (Basel) (2016) 0.75
Taking dendritic cells into medicine. Nature (2007) 11.82
Transdermal drug delivery. Nat Biotechnol (2008) 5.11
The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol (2005) 4.52
Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol (2004) 3.57
Dissolving polymer microneedle patches for influenza vaccination. Nat Med (2010) 3.24
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis (2008) 3.05
Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ (2003) 2.99
Effect of microneedle design on pain in human volunteers. Clin J Pain (2008) 2.48
Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med (2002) 2.42
Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med (2010) 2.21
Microneedle-based vaccines. Curr Top Microbiol Immunol (2009) 2.17
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial. BMJ (2008) 2.17
Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res (2002) 2.13
Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine (2008) 2.07
Immunization without needles. Nat Rev Immunol (2005) 2.02
Cutaneous dendritic cells. Semin Immunol (2005) 1.94
Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine (2007) 1.89
The immunobiology of muscle. Immunol Today (1994) 1.83
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine (2005) 1.79
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release (2009) 1.62
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med (2005) 1.61
Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine (2009) 1.55
Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis (2004) 1.53
Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med (2005) 1.48
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine (2009) 1.37
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis (2010) 1.36
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther (2003) 1.35
Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin (2005) 1.34
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One (2010) 1.27
Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol (2004) 1.27
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine (2008) 1.26
Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol (2010) 1.22
Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther (2001) 1.22
Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol (2007) 1.17
Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine (2009) 1.16
The effect of heat on skin permeability. Int J Pharm (2008) 1.11
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther (2010) 1.11
Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release (2009) 1.08
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release (2010) 1.05
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res (2010) 1.03
Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine (2002) 1.03
Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine (2005) 1.00
Influence of needle gauge in Mantoux skin testing. Chest (1994) 0.98
Combination of radiofrequency ablation and immunotherapy. Front Biosci (2008) 0.95
Immune functions of the skin. Clin Dermatol (2001) 0.95
Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine (2008) 0.94
Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine (2005) 0.94
Needle-free liquid jet injections: mechanisms and applications. Expert Rev Med Devices (2006) 0.93
Transcutaneous immunization using common chemicals. J Control Release (2009) 0.93
Epidermal powder immunization against influenza. Vaccine (2004) 0.91
Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur J Pharm Sci (2009) 0.90
Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm (2008) 0.90
A systematic review of measures for reducing injection pain during adult immunization. Vaccine (2009) 0.82
Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci (1998) 2.80
Lack of pain associated with microfabricated microneedles. Anesth Analg (2001) 2.38
Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57
Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability. J Acoust Soc Am (2001) 1.44
Quantitative study of electroporation-mediated molecular uptake and cell viability. Biophys J (2001) 1.37
Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng (2000) 1.37
Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. J Acoust Soc Am (2001) 1.13
Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res (1998) 1.11
Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. J Pharm Sci (2001) 1.11
Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther (2010) 1.11
Frequency dependence of sonophoresis. Pharm Res (2001) 1.09
Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ (2011) 1.05
Prediction and optimization of gene transfection and drug delivery by electroporation. Gene Ther (2001) 0.97
Intracellular drug delivery using low-frequency ultrasound: quantification of molecular uptake and cell viability. Pharm Res (2001) 0.95
Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J Pharm Sci (1996) 0.91
Predicted permeability of the cornea to topical drugs. Pharm Res (2001) 0.90
Saving cells from ultrasound-induced apoptosis: quantification of cell death and uptake following sonication and effects of targeted calcium chelation. Ultrasound Med Biol (2010) 0.90
Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity. Int J Pharm (2002) 0.89
Sonoluminescence as an indicator of cell membrane disruption by acoustic cavitation. Ultrasound Med Biol (2001) 0.89
Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound. Br J Cancer (2005) 0.88
Magainin-mediated disruption of stratum corneum lipid vesicles. Pharm Res (2001) 0.87
The effect of intraocular pressure on human and rabbit scleral permeability. Invest Ophthalmol Vis Sci (1999) 0.85
Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm Res (2000) 0.84
Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol (1998) 0.84
Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res (1997) 0.82
Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res (1996) 0.82
Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. J Control Release (2012) 0.79
Heparin alters transdermal transport associated with electroporation. Biochem Biophys Res Commun (1997) 0.78
Electrical impedance spectroscopy for rapid and noninvasive analysis of skin electroporation. Methods Mol Med (2000) 0.77
Investigations of needle-free jet injections. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
Measurement of rapid release kinetics for drug delivery. Pharm Res (1995) 0.75